Opthea Ltd at Oppenheimer Healthcare Conference (Virtual) Transcript
Great. Thank you so very much. Again, thanks to the operators for making this so easy. People, I think, have little idea of how much technical stuff -- hurdles need to be overcome.
We have with us Megan Baldwin and Tim from Opthea. I've gotten to know Tim just recently; Megan for a very, very, very long period of time. And Megan has been doing stellar work in getting Opthea in two Phase 3 trials in wet AMD, with some really great data in Phase 2, both in wet AMD and DME. And we'll talk about that today.
So both of you, welcome. I really appreciate having you here.
Thanks, Hartaj.
Thanks, Hartaj.
And maybe what we can do is -- Megan, if you want to just give us about a five-minute overview of where the company is now, and then we can go from there.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
